7362 J . Org. Chem., Vol. 63, No. 21, 1998
Wang and Silverman
300 MHz) 142.56, 139.49, 136.50, 128.72, 128.26, 127.49,
126.39; MS (EI) m/z 258 (M - H+), 132, 115, 77; HRMS (EI)
calcd for C9H10NI (M - H+) 259.9781, found 257.9785. Anal.
Calcd for C16H18NO3SI (tosylate salt): C, 44.56; H, 3.91; N,
3.25. Found: C, 44.34; H, 3.93; N, 3.17.
2-[(E)-2-Iod oeth en yl]ben za ld eh yd e (12). To a vigorously
stirred suspension of PCC (1.20 g, 5.57 mmol) in anhydrous
dichloromethane (20 mL) was added vinyl iodide 10 (1.00 g,
3.9 mmol). The reaction mixture was stirred for 2 h before 20
mL of ether was added. The solution was filtered through a
pad of silica gel and concentrated to give 12 as a colorless oil:
1H NMR (CDCl3, 300 MHz) δ 10.21 (s, 1H), 8.28-8.33 (d, 1H),
7.48-7.80 (m, 4H), 6.87-6.92 (d, 1H); 13C NMR (CDCl3, 300
MHz) 192.20, 141.85, 139.59, 134.00, 132.43, 132.05, 128.59,
127.52, 81.83; MS (EI) m./z 131, 103, 77, 51; HRMS (EI) calcd
for C9H7OI (M+) 257.9543, found 257.9538. The compound
slowly decomposed, prohibiting elemental analysis.
128.64, 128.58, 128.49, 128.40, 127.67, 126.97; MS (EI) m/z
497 (M - H+), 371, 245, 130, 116; HRMS (EI) calcd for C18H15
-
NI2 (M - H+) 497.9216, found 497.9218.
2-[(Z)-2-Iod oeth en yl]ben zyl Iod id e (18). To a solution
of the sulfonate ester 16 (62 mg, 0.19 mmol; prepared by the
same procedure as 11) in anhydrous acetone (5 mL) was added
a solution of sodium iodide (67.5 mg, 0.45 mmol) in acetone
(10 mL). The solution was allowed to reflux overnight. The
solvent was removed, water (10 mL) was added, and the
solution was extracted with ether (3 × 10 mL). The organic
layers were combined, dried, concentrated, and chromato-
graphed to afford 18 as a white solid: mp 40-42 °C; the color
changes rapidly upon exposure to light; 1H NMR (CDCl3, 300
MHz) δ 7.36-7.42 (m, 3H), 7.28-7.30 (m, 2H), 6.83-6.86 (d,
1H), 4.38 (s, 2H); 13C NMR (CDCl3, 300 MHz) δ 138.72, 138.29,
137.55, 130.59, 130.43, 129.87, 129.17, 86.25, 5.33; MS (EI)
m/z 370 (M+), 254, 243, 116, 63; HRMS (EI) calcd for C9H8I2
(M+) 369.8716, found 369.8713.
2-[(Z)-2-Iod oeth en yl]ben za ld eh yd e (14). To a stirred
suspension of (iodomethyl)triphenylphosphonium iodide18 (1.80
g, 3.2 mmol) in anhydrous THF (15 mL) was added sodium
hexamethyldisilazine (1 M, 3.2 mL) dropwise. After it was
stirred for 1 min, the solution was cooled in a dry ice-acetone
bath and HMPA (1 mL) was added. The above orange solution
was transferred via cannula slowly to a solution of phthalic
dicarboxaldehyde (1.72 g, 12.8 mmol) in THF (20 mL) at -78
°C. The cold bath was then removed, and stirring was
continued for 30 min. Hexane (40 mL) was added to the
reaction mixture. After filtration, the filtrate was washed with
water (3 × 15 mL) and brine (20 mL), dried over Na2SO4,
concentrated and chromatographed (11% EtOAc/89% hexane)
to give 14 (350 mg, 42%), which was inseparable from its trans
isomer. An analytical sample was obtained by column chro-
matographic separation of the corresponding alcohol 15 (see
below) followed by PCC oxidation: 1H NMR (CDCl3, 300 MHz)
δ 10.20 (s, 1H), 7.94-7.96 (d, 1H), 7.78-7.80 (d, 1H), 7.53-
7.68 (m, 3H), 6.89-6.92 (d, 1H); 13C NMR (CDCl3, 300 MHz)
δ 192.33, 141.02, 138.24, 134.32, 133.71, 131.21, 130.34,
129.19, 86.80; HRMS (EI) calcd for C9H7OI (M+) 257.9543,
found 257.9534. The compound slowly decomposed, prohibit-
ing elemental analysis.
2-[(Z)-2-Iod oeth en yl]ben zyl Alcoh ol (15). Compound 15
was prepared by the same method as 10 by NaBH4 reduction
of 14: mp 54-55 °C; 1H NMR (CDCl3, 300 MHz) δ 7.27-7.49
(m, 5H), 6.72-6.75 (d, 1H), 4.64 (s, 2H); 13C NMR (CDCl3, 300
MHz) δ 138.25, 138.12, 136.78, 128.70, 128.54, 128.02, 127.71,
84.70, 63.44; MS (EI) m/z 260 (M+), 133, 105, 77, 51; HRMS
(EI) calcd for C9H9IO (M+) 258.9699, found 259.9703. Anal.
Calcd for C9H9OI: C, 41.56; H, 3.49; Found: C, 41.60; H, 3.48.
2-[(Z)-2-Iod oeth en yl]ben zyla m in e (3b). Compound 3b
was prepared from 15 by the same method used to make 3a
from 10. It was analyzed as the HCl salt. The sulfonate ester
16 was first obtained: 1H NMR (CDCl3, 400 MHz) δ 7.43-
7.50 (m, 5H), 6.82-6.84 (d, 1H), 5.22 (s, 2H), 2.90 (s, 3H).
Compound 3b (HCl salt): mp 202-204 °C dec; 1H NMR
(D2O, 300 MHz) δ 7.48-7.54 (m, 5H), 6.96-6.99 (d, 1H), 4.16
(s, 2H); 13C NMR (D2O, 300 MHz) δ 138.64, 137.76, 129.82,
129.50, 129.32, 129.21, 129.00, 88.10, 40.59; MS (EI) m/z 258
(M+), 132, 115, 77, 51; HRMS (EI) calcd for C9H10IN (M+)
257.9781, found 257.9788. Anal. Calcd for C9H11NClI (HCl
salt): C, 36.58; H, 3.75; N, 4.74. Found: C, 36.28; H, 3.76; N,
4.86.
N-{2-[(Z)-2-Iodoeth en yl]ben zyliden e}m eth ylam in e (19).
A solution of 14 (10 mg, 0.04 mmol) and p-toluenesulfonic acid
hydrate (1.5 mg, 0.008 mmol) in benzene (5 mL) was bubbled
with methylamine for 3 min. The reaction mixture was stirred
for 1 h, washed with saturated Na2CO3 (3 mL), dried over
Na2SO4, and concentrated to afford 19 as a yellow oil (10 mg,
90%): 1H NMR (CDCl3, 300 MHz) δ 8.42 (d, 1H), 7.94-7.96
(m, 1H), 7.59-7.62 (d, 1H), 7.38-7.45 (m, 3H), 6.79-6.82 (d,
1H), 3.53 (d, 3H); MS (EI) m/z 272 (MH+), 144, 103, 55; HRMS
(EI) calcd for C10H11IN (MH+) 271.9936, found 271.9949.
N-{2-[(E)-2-Iodoeth en yl]ben zyliden e}m eth ylam in e (20).
Compound 20 was prepared in a manner identical with that
for 19, starting from 12: 1H NMR (CDCl3, 300 MHz) δ 8.56
(d, 1H), 7.97-8.02 (d, 1H), 7.79-7.80 (d, 1H), 7.35-7.38 (m,
3H), 6.72-6.77 (d, 1H), 3.56 (d, 3H); MS (EI) m/z 270 (M -
H+), 229, 144, 131, 115, 103, 77; HRMS (EI) calcd for C10H9NI
(M - H+) 269.9780, found 269.9766.
En zym e a n d Assa y. Beef liver MAO B was isolated as
described previously19 and stored as a concentrated solution
(15-25 mg/mL) in sodium phosphate buffer (50 mM, pH 7.2)
at 4 °C. The specific activity varied among preparations,
ranging from 3.5 to 7 units/mg, where a unit of activity is the
conversion of 1 µmol of benzylamine to benzaldehyde per
minute at pH 9.0 and 30 °C.
Gen er a l P r oced u r e in Or ga n ic Solven t. Stock MAO (40
µL) was pipetted into a vial, frozen in a -78 °C dry ice-acetone
bath, and lyophilized. The substrate solution (6 mM, 1000 µL)
was syringed into the vial containing the dried enzyme; water
was pipetted into the mixture to give a final water concentra-
tion of 0.5% (v/v). The mixture was sonicated for 10 s in an
ultrasonic cleaning bath. For analysis, 1 µL aliquots were
periodically removed and analyzed by capillary gas chroma-
tography.
Gen er a l P r oced u r e for In h ibition of th e MAO-Ca ta -
lyzed Oxid a tion of Cin n a m yla m in e. An MAO solution was
prepared by diluting 15 µL of the stock MAO solution with
285 µL of Tris-HCl buffer (100 mM, pH 9.0). The amount of
inhibition of the oxidation of various concentrations of cin-
namylamine (0.2, 0.35, 0.50, and 0.67 mM in Tris-HCl buffer,
100 mM, pH 9.0) by various concentrations of inhibitor 3a (0,
0.2, 0.4, 0.6, 0.8 mM in Tris-HCl buffer, 100 mM, pH 9.0) was
determined by adding 10 µL of the above MAO solution to 490
µL of an inhibitor/substrate solution at 25 °C, followed by
monitoring the increase in absorbance at 290 nm. Up to 30%
anhydrous DMSO was used as the cosolvent to dissolve 3a .
An enzyme control was incubated in DMSO-containing buffer
to factor out any effects of the cosolvent on the enzyme activity.
The Ki value was determined by a Dixon plot.20
Con d en sed Im in e of 3b a n d 14 (17). To a solution of the
free amine form of 3b (16.62 mg, 0.064 mmol) in benzene (5
mL) was added aldehyde 14 (16.5 mg, 0.064 mmol) in 5 mL of
benzene. The solvent was removed in vacuo, and benzene was
added and evaporated a couple of times to get rid of the water.
Compound 17 was obtained as a yellowish oil: 1H NMR
(CDCl3, 300 MHz) δ 8.48 (s, 1H), 8.02 (d, 1H), 7.60-7.62 (d,
1H), 7.52-7.55 (d, 1H), 7.32-7.49 (m, 7H), 6.78-6.81 (d, 1H),
6.71-6.74 (d, 1H), 4.67 (s, 2H); 13C NMR (CDCl3, 300 MHz)
160.36, 138.86, 138.65, 138.48, 136.91, 133.17, 130.33, 128.80,
Meta bolite Stu d ies. To a solution of 3b (12.4 mM) in Tris-
HCl buffer (3.0 mL, 100 mM, pH 9.0) was added MAO B (220
µL, 17.75 mg/mL). Aliquots of 20 µL were periodically
withdrawn, extracted with 40 µL of methylene chloride by
(19) Weyler, W.; Salach, J . I. Arch. Biochem. Biophys. 1981, 212,
147-153.
(20) Price, N. C.; Stevens, L. Fundamentals of Enzymology; Oxford
University Press: Oxford, U.K., 1989, pp 178-179.
(18) Seyferth, D.; Heeren, J . K.; Singh, G.; Grim, S. O.; Hughes, W.
B. J . Organomet. Chem. 1966, 5, 267-274.